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A B ST R AC T 
 
 
Necrotizing fasciitis is a rapidly destructive affliction of soft tissues, with a 
mortality rate that may reach 73% of the cases. It is characterized by a 
progressive inflammation and extended necrosis of the subcutaneous tissue and 
the fascia. Necrotizing fasciitis was first described in 1848, and later in 1920 
Meleney identified 20 patients in China in which the infection was presumably 
triggered by hemolytic streptococcus, linking pathological bacteria to the 
condition. In 1952, Wilson coined the term necrotizing fasciitis although without 
successfully identifying the specific pathological bacteria involved. In most 
cases, both risk and aggravating factors are present, the main risk factors being 
diabetes mellitus, liver cirrhosis, renal failure, and immunosuppressant states. 
Location may vary, but most frequently the disease occurs in the limbs, the 
trunk, and the perineum. Treatment depends on the location and the time of 
diagnosis and may range from large incisions with extensive debridement to 
organ amputations such as those of the limbs or breasts. Treatment is complex 
and expensive, and besides surgery, includes the administration of broad-
spectrum antibiotics, anti-inflammatory drugs, intensive therapy support, and 
long-term hospitalizations. The prognosis is guarded. The present case entails a 
56-year old female patient who presented with many risk factors favoring the 
occurrence of necrotizing fasciitis, namely diabetes mellitus, liver cirrhosis 
(decompensated with ascites and portal encephalopathy phenomena), untreated 
hepatitis B infection, chronic renal failure with diabetic nephrotic syndrome, and 
obesity.   
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Introduction  
Necrotizing fasciitis has been defined as a severe 
infection of soft tissues which includes extended necrosis 
of the fascia and the subcutaneous tissue, with the relative 
sparing of the muscles and skin [1]. As the disease 
progresses, the thrombosis of cutaneous perforants will 
cause the devascularization of the skin, leading to its 
necrosis. Sepsis will invariabley develop, depending on the 
bacteriological cultures. There are 3 types of necrotizing 
fasciitis: type I consists of polymicrobial infections, type II 
consists of group A streptococcal infections alone or 
associated with Staphylococcal infections, and type III 
consists of Vibrio species infections. However, recent 
studies have revealed that the microbial flora is constantly 
undergoing change and is becoming increasingly resistant 
to antibiotics, for example, with reported cases in which the 
Staphylococcus aureus has been resistant, including to 
Methicillin [2]. Moreover, given that necrotizing fasciitis 
most often occurs on biological soil, bacteria with 
increased aggressiveness may also be involved, for 
example Klebsiella pneumonia [3]. Despite aggressive 
treatment, the mortality rate remains high, ranging between 
52 and 72% [4,5]. In most cases, necrotizing fasciitis 
occurs when there is decreased immunity, being associated 
with diseases such as myelodysplastic syndrome, liver 
cirrhosis, diabetes mellitus, cancer, and chronic obstructive 
arteriopathy [6-8]. 
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Case Report 
A 56-year-old female patient presented to the surgical 
unit with painful right inguinal adenopathy. Clinically, the 
presence of a right inguinal adenopathy of about 4/2/2/ cm 
was noticed. It was mobile, well outlined, painful 
spontaneously and also upon palpation. The patient 
presented with associated decompensated type II diabetes 
mellitus, liver cirrhosis decompensated both 
parenchymatously and vascularly, with ascites occurring 
due to a HBV infection, alcohol consumption, and obesity. 
Preoperative tests also revealed moderate anemia (Hb=9.8 
mg/dl) and chronic renal failure, probably due to diabetic 
nephropathy (creatinine 1.4), while the inter-clinical 
consultation on internal medicine also revealed stage II 
AHT.  
Despite the associated pathology, and after the 
preliminary postponement of the surgical intervention, the 
patient insisted on the surgical removal of the inguinal 
ganglion, on the one hand, because of the local pain, and 
on the other hand because of the suspicion of the family 
doctor of a possible lymphoma at onset.  
The ablation of the inguinal ganglion was performed 
under local anesthesia, through a minimally invasive 
approach, a horizontal incision at approximately 4-5 cm 
under the inguinal arch, about 5-6 cm long. The immediate 
postoperative evolution was favorable, without any 
complications.  
On admission, the patient had been on a course of self-
administerd Augmentin for 3 days. Two days after the 
intervention, the patient requested the discharge, and 6 
hours later she returned, indicating pain at the incision site. 
Locally, the patient presented slight edema and erythema 
along with mild pain. She was re-operated on and the local 
necrosis of the fascia was noticed. It was debrided and 
broad-spectrum antibiotic therapy was initiated (Meronem 
with Vancomycin), as well as volemic support. The 
cultures showed the presence of enterococcus. Despite the 
established medication, the necrotizing fasciitis 
extended, the incisions were enlarged, with massive 
debridement, but the blood glucose level could not be 
established.  
Given the low immunity determined by 
decompensated liver cirrhosis, the HBV infection, and 
decompensated diabetes mellitus, the general condition 
of the patient progressively worsened, with the decrease 
in plasma levels of hemoglobin and albumin, with 
hydro-electrolytic imbalances, metabolic acidosis etc., 
which could not be compensated despite all the efforts. 
The patient died 3 weeks after the onset of the 
necrotizing fasciitis.  
Discussions 
Early diagnosis of necrotizing fasciitis is difficult 
because the first manifestations consist of edema, 
erythema, and possible mild paresthesia. Laboratory test 
results are unchanged from those in the first stage of the 
disease [9]; as a result, the condition is often diagnosed late 
when the first complications have already occurred. Since 
there are no specific signs or symptoms for diagnosis, we 
considered that the first step in the diagnosis of necrotizing 
fasciitis is its suspicion at the smallest signs of local 
inflammation, in immunosuppressed patients and with 
favoring factors.   
Once suspected or diagnosed, the protocol treatment for 
necrotizing fasciitis includes: 
1. Assessment of the biological field, co-morbidities, and 
aggravating and prognostic factors; 
2. Large and extensive incisions, with the debridement of 
all necrotizing tissues; 
3. Broad-spectrum antibiotic therapy; 
4. Intensive therapy with inotropic support medication 
which supports blood pressure at values higher than 65 
mm Hg; 
5. Reconstructive surgery. 
The assessment of the biological field is done first 
through a thorough case history and the study of the 
patient’s medical history in order to identify associated 
diseases, and second, through detailed laboratory tests: a 
complete blood count, ionogram, C-reactive protein, blood 
glucose levels, stress hyperglycemia ratio (IQR), HbA1c, 
glycemic variation (the difference between the level of 
hyperglycemia and that of hypoglycemia), urea, sodium, 
albumin, creatinine, liver transaminases, GGT, ALP, 
bilirubin. Additionally, glycosylated hemoglobin, AgHBs, 
HCV, HIV, uric acid, etc. can also be ordered [8-10]. 
The value of blood glucose levels and glycemic 
variations is currently a debated topic. Many critical 
illnesses cause stress-induced hyperglycemia by producing 
excessive catecholamine, glycogen, and inflammatory 
cytokines, thus leading to the increase of glucogenesis and 
insulin resistance [11]. Yet hyperglycemia may also be a 
distinctive sign of severity in patients with associated 
diseases [12]. Egi et al. have demonstrated that acute 
hyperglycemia can affect mortality in diabetic patients 
with other critical illnesses [13]. However, glycated 
hemoglobin (HbA1c) is not influenced by acute stress or 
sepsis [14].  
Po-Chuan Chen et al. conducted a study on 252 
patients, which focused on the role of glycemic variation 
as a predictive factor for necrotizing fasciitis. This study 
revealed that a glycemic variation ≥ 146 mg/dl with or 
without hyperglycemia on admission and with an 
APACHE II score ≥ 15, had favored the development of 
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complications in patients with necrotizing fasciitis, 
especially bacteremia and acute renal failure. Thus, it was 
used as a predictive factor in the occurrence of 
complications and the evaluation of the prognosis in 
patients with necrotizing fasciitis [8]. 
The American Society of Anesthesia (ASA) has 
developed a system of evaluation for the systemic 
inflammatory response syndrome (SIRS) that we find 
useful (Table 1). 
In the case of monomicrobial infections, the most 
frequently implicated germs are group A streptococcus, 
group B streptococcus, staphylococcus aureus, aeromonas 
hydrophilia, vibrio vulnificus, Escherichia colli, klebsiella 
pneumoniae, and pseudomonas aeruginosa, while in the 
case of plurimicrobial infections, there may be various 
combinations of these germs [15]. Approximately 60-80% 
of the infections related to necrotizing fasciitis are 
monomicrobial [16, 17]. Finegoldia magna may also be 
implicated when determining microbial infections in the 
case of necrotizing fasciitis in the diabetic patient [18]. 
Finegoldia magna is a Gram-positive anaerobic coccus of 
the Clostridiales family, which together with other Gram-
positive anaerobic cocci (GPAC), had been known until 
1999 to be part of Peptostreptococcus magnus, being a 
pathogenic germ that normally colonizes the skin and the 
mucous membranes, but which can cause severe infections 
in case of low immunity, as in the case of a diabetic patient 
[19,20]. The Klebsiela Pneumoniae infections are 
associated with an increased risk of death [15] (Table 1). 
Table 1. The evaluation system of the Systemic Inflammatory Response Syndrome (SIRS) [15]. 
Variable Definition  
Diabetes mellitus 
The diagnosis is based on one of the four abnormalities identified by the American Diabetes 
Association, 2010: glycated hemoglobin (A1C) ≥6.5%, fasting plasma glucose (FPG) ≥126 
mg/dl, random plasma glucose ≥200 mg/dl with symptoms, or two-hour plasma glucose 
≥200 mg/dl during an oral glucose tolerance test (OGTT) 
Functional Status 
Patient requiring no, partially, or totally dependent assistance from another person for 
regular daily activities before surgery 
Hypertension Patient with elevated blood pressure requiring medication 
Chronic renal failure 
Patient with increasing creatinine levels >3 mg/dl or a decreased glomerular filtration rate 
of less than 60 ml/min/1.73 m2 for 3 or more months 
Liver cirrhosis Diagnosis based on clinical, laboratory, and echographic findings 
SIRS 
Includes the presence of two or more of the following: temperature >38 °C or <36 °C, heart 
rate >90 bpm, respiratory rate >20 breaths/min or PaCO2 < 32 mm/Hg, WBC >12,000/mm3 
or <4,000/mm3, or >10 % immature (band) forms, anion gap acidosis 
Septic shock  Includes sepsis and documented organ and/or circulatory dysfunction 
Limb loss Amputation of the lower or upper limb above the ankle or the wrist, respectively. 
ASA score 1 = normal healthy patient 
2 = patient with mild systemic disease 
3 = patient with severe systemic disease 
4 = patient with severe systemic disease that is a constant threat to life 
5 = moribund patient who is not expected to survive without the operation 
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 The most frequent location of necrotizing fasciitis is 
by far the lower limb, followed by the upper limb, the 
trunk, and the neck, in order of the incidence [15, 21-24]. 
The development of peripheral diabetic micro- and 
macroangiopathy in the lower limb of the diabetic patient 
is the main factor that favors the location of necrotizing 
fasciitis, especially in the lower limb of the diabetic patient. 
The treatment of choice for necrotizing fasciitis in the 
pelvic limb consists of large incisions and necrectomy, the 
amputation of the thigh being the last resort in saving the 
patient’s life [25]. The development of necrotizing fasciitis 
in the genital and perineal regions is known as Fournier’s 
gangrene, with an incidence of 0.4-1/100,000, with a slight 
increase in incidence in recent years. As in most cases of 
necrotizing fasciitis, the inoculation gate of germs is small 
[26]. However, it may also occur in less common 
anatomical regions, such as the breast, in which case the 
mortality is 72% (5), the youngest patient reported with 
such a location of the disease was only 23 years old, non-
diabetic, and the only pathogenic association being obesity 
[27].  
Most cases of necrotizing fasciitis of the breast have 
been reported during lactation, with only 6 cases currently 
reported unrelated to lactation [27]. In the case of 
necrotizing fasciitis of the breast, mortality can be reduced 
by up to 10% if an early diagnosis is made and the rapid 
establishment of the surgical treatment is possible, through 
massive debridement, antibiotic therapy, and anti-
inflammatory treatment, along with support of volemic and 
hydro-electrolytic balance [28]. The cervical location of 
necrotizing fasciitis is also extremely rare, but not 
excluded, such cases being reported, sometimes even with 
and odontogenic starting point, the main determinism 
being pulp necrosis with the bacterial invasion of the 
periapical tissue, leading to the formation of purulent 
collections [29]. The periorbital area where the fascia is 
poorly represented is also not excluded from such 
pathology, cases of periorbital necrotizing fasciitis having 
reported local trauma, either accidental or iatrogenic 
(surgical), the prognosis being better in such cases. 
However, there is the possibility of complications such as 
optic neuropathy, retinal vein occlusion, keratopathy, 
cavernous sinus thrombosis, meningitis, vision loss and 
death [30-32]. 
The treatment for necrotizing fasciitis is complex and 
multimodal, consisting of broad-spectrum antibiotic 
therapy, anti-inflammatory drugs, hemodynamic support, 
hemodynamic rebalancing, surgical treatment of 
cleanliness, and reconstruction. The antibiotic treatment 
is generally done with broad-spectrum antibiotics from 
the penicillin and cephalosporin classes, and, of course, is 
dictated by the microbial flora involved and its resistance 
and sensitivity to antibiotics [33]. In cases of microbial 
flora resistant to the usual antibiotics, Vancomycin is 
most often administered. The knowledge of the microbial 
flora generally involved in the occurrence of necrotizing 
fasciitis and its sensitivity can usually help establish an 
efficient antibiotic treatment from the outset and thus 
save the patient’s life.  
Surgical treatment can vary from the simple 
debridement to the disarticulation of the limb from the 
coxo-femoral joint [34]. Based on recent studies regarding 
predictive factors for pelvic limb amputation, the 
occurrence of necrotizing fasciitis in this limb in diabetic 
patients has an amputation rate that reaches 95%, 
compared with an amputation rate of 14.2% in all diseases 
for diabetic patients, having by far the highest amputation 
rate of the lower limb [35]. Compared to non-diabetic 
patients, the plurimicrobial infection rate and the 
amputation rate due to necrotizing fasciitis is significantly 
higher in patients with necrotizing fasciitis and diabetes 
[36].  
As a therapeutic alternative, negative pressure vacuum 
can be used. It may also be used as a first therapeutic 
alternative in the necrosis of the breast [27, 37]. Neumaier 
suggests that negative pressure wound therapy (NPWT) 
may be superior to negative pressure systems, especially 
for aggressive infectious wounds which release many 
endotoxins and necrotic defects, as the negative pressure 
system facilitates removal of interstitial fluids [38]. NPWT 
systems work by introducing positive pressure in the 
wound bed. This creates an area of local hypoxic tissue 
which is surrounded by an area of hyperemia in the 
perilesional tissue [39]. Moreover, following the 
application of NPWT, debridement is accelerated in a 
manner similar to autolyzed debridement, and physical 
debridement is favored by the granulation tissue growth as 
well as by the local growth factors, thus facilitating healing 
[40]. Gabriel et al. reported that NPWT combined with 
topical irrigation after debridement is superior to standard 
NPWT treatment for infection control; this combination 
treatment may decrease the healing time, the length of the 
hospital stays, and the duration of the therapy [41]. Along 
similar lines, Matiasek et al. reported a case study that 
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combined NPWT with application of octenidine in the 
wound, arguing that it would facilitate more rapid healing 
of the wound [42]. 
The most concerning complications of necrotizing 
fasciitis are: (1) acute renal lesions (defined as increases 
in serum creatinine level > 0.5 mg / dL compared to prior 
to or upon admission); (2) acute respiratory failure that 
requires orotracheal intubation and mechanic ventilation 
support; (3) bacteremia (defined as positive blood 
culture); (4) septic shock (defined by the clinical criteria 
of sepsis and the need for vasopressor therapy necessary 
to maintain an average blood pressure of 65 mm Hg and 
lactate > 2 mmol / L in the absence of hypovolemia); and 
(5) death. Wound healing may also be influenced by the 
type of the bacteria involved, and systemic antibiotic 
therapy may involve disturbances of the adjacent 
cutaneous microbioma or distal ones in the presence of 
comorbidities [15,43-51].  
Table 2. LRINEC Score [52]. 
Biologic 
Parameter 
Value Score 
Reactive C Protein 
Under 15 mg/dl 0 
Over 15 mg/dl 4 
Leukocyte  
Under 15,000 /µl 0 
15,000-25,000 /µl 1 
Over 25,000 /µl 2 
Hemoglobin 
Over 13.5 mg/dl 0 
11-13.5 mg/dl 1 
Under 11 mg/dl 2 
Serum Sodium   
Over 135 mEq/l 0 
Under 135 mEq/l 2 
Creatinine 
Under 1.6 mg/dl 0 
Over 1.6 mg/dl 2 
Glucose 
Under 180 mg/dl 0 
Over 180 mg/dl 1 
For evaluation of the severity of necrotizing fasciitis, 
as well as for the prognosis, we consider prediction scores 
to be helpful. The most widely used is the LRINEC 
(Laboratory Risk Indicator for Necrotizing Fasciitis) 
score (Table 1). This score classifies patients into three 
groups: 
• low risk (LRINEC score ≤ 5 points, <50% risk of 
necrotizing fasciitis); 
• moderate risk (LRINEC score 6-7 points, 50%-75% 
risk of necrotizing fasciitis);  
• high risk (LRINEC score ≥ 8 points,> 75% risk of 
necrotizing fasciitis).  
Studies on the LRINEC score have shown that a score 
≥ 6 as a reduction of necrotizing fasciitis gave a positive 
predictive value (PPV) of 92% and a negative predictive 
value (NPV) of 96%. Approximately 90% of patients with 
necrotizing fasciitis had LRINEC scores ≥6 points, while 
only 3.1% up to 8.4% of the control-group patients had 
LRINEC scores ≥ 6 points. 10% of the patients with 
necrotizing fasciitis had a LRINEC score < 6 [52, 53] 
(Table 2).  
Wagner’s score can also be useful as predictive factors 
in evaluating lesions of the diabetic foot [54-56].  
For the evaluation of the general state of the patient, of 
the severity of the disease and the general prognosis, the 
APACHE II score can provide good results [57] (Table 3 
and 4). 
Table 3. Wagner’s Classification for diabetic ulcer 
patients [53]. 
Degree  The description of the injury 
0 Intact Skin 
I Superficial ulcer of skin or subcutaneous 
tissue 
II Ulcers extend into the tendon, bone or 
capsule 
III Deep ulcer with osteomyelitis or abscess 
IV Partial foot gangrene 
V Whole foot gangrene 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alexandra Toma et al.  
 124 
  
Table 4. Apache II Score [54]. 
Physiologic 
variable 
Point score 
+4 +3 +2 +1 0 +1 +2 +3 +4 
1 Temperature  ≥41 39-40 - 38.5-38.9 36-38.4 34-35 32-33 30-31 ≤29.9 
2 Mean 
arterial 
pressure 
(mmHg) 
≥160 130-159 110-129 - 70-109 - 50-69 - ≤49 
3 Heart rate ≥180 140-179 110-139 - 70-109 - 55-69 40-54 ≤39 
4 Respiratory 
rate 
≥50 35-49 - 25-34 12-24 10-11 6-9 - ≤5 
5 Oxygenation  
a) FiO2≥0.5 
b) FiO2≤0.5 
 
≥500 
- 
 
350-499 
- 
 
200-349 
- 
 
- 
- 
 
<200 
>70 
 
- 
61-70 
 
- 
- 
 
- 
55-60 
 
- 
<55 
6 Arterial pH ≥7.7 7.6-7.69 - 7.5-7.59 7.33-7.49 - 7.25-7.32 7.15-7.24 <7.15 
7 Serum Na 
(mMol/L) 
≥180 160-179 155-159 150-154 130-149 - 120-129 111-119 ≤110 
8 Serum K 
(mMol/L) 
≥7 6-6.9 - 5.5-5.9 3.5-5.4 3-3.4 2.5-2.9 - ≤2.5 
9 Serum 
creatinine 
(mg/dl) 
≥3.5 2-3.4 1.5-1.9 - 0.6-1.4 - <0.5 - -- 
10 Hct (%) ≥60 - 50-59.9 46-49.9 30-45.9 - 20-29.9 - <20 
11 WBC (in 
1000) 
≥40 - 20-39.9 15-19.9 3-14.9 - 1-2.9 - <1 
12 Glasgow 
coma score  
Score 
-15 
minus 
actual 
GCS 
        
The acute physiology score is the sum of the 12 individual variable points. 
Add 0 points for the age < 44; 2 points for 45-54 years; 3 points for 55-64; five points for 65-74 years and six points 
≥75 years. 
APACHE II Score – acute physiology score + age points + Chronic health points. The maximum score is 71. 
Increasing score is associated with increasing risk of hospital death. 
Add chronic health status points: two points in elective postoperative patient with immuno-compromised state or a 
history of severe organ failure: five points for non-operative patient or emergency postoperative patient with 
immuno-compromised state or severe organ failure. 
13d Serum 
HCO3 
(venous –
mMol/l) 
≥52 41-51.9 - 32-40.9 22-31.9 - 18-21.9 15-17.9 <15 
Interpretation of APACHE II Scores: 
0-4: ~4% death rate; 5-9: ~8% death rate; 10-14: ~15% death rate; 15-19: ~25% death rate; 20-24: ~40% death rate; 
25-29: ~55% death rate; 30-34: ~75% death rate; over 34: ~85% death rate 
a APACHE II Score – acute physiology score + age points + Chronic health points. The maximum score is 71. 
Increasing score is associated with increasing risk of hospital death 
b choose the worst value in the past 24 h 
c chronic health status: organ failure or an immuno-compromised state must have preceded current admission 
d optional variable 
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Highlights 
✓ Necrotizing fasciitis is a severe infection of soft tissue 
with extended necrosis of the fascia and subcutaneous 
tissue and may involve muscles and skin. 
✓ Necrotizing fasciitis is common in patients with 
diabetes mellitus, with high mortality for these 
patients. 
Conclusions 
Although diabetes mellitus is a risk factor for the 
occurrence of necrotizing fasciitis, no major differences in 
mortality between those with and without diabetes mellitus 
occurs. Thus, we can conclude that although necrotizing 
fasciitis is favored by diabetes mellitus, once installed, its 
mortality is equally high irrespective of the patient’s 
diabetes status. However, if it is also associated with other 
co-morbidities besides diabetes mellitus, such as liver 
cirrhosis or immune-depression, the risk of death increases 
greatly. The diagnosis is extremely difficult, as there are 
practically no specific signs or symptoms or conclusive 
laboratory investigations. The tentative diagnosis is the 
suspicion of fasciitis in a patient with low immunity, which 
is confirmed after incisions reveal fasciitis. Treatment is 
complex, with broad-spectrum antibiotic therapy, volemic 
and hydroelectrolytic support, the treatment of associated 
diseases. Surgical treatment consists of large incisions and 
extended fasciectomies, followed by plastic reconstruction. 
Still, the prognosis is poor, with a mortality rate that can 
even reach up to 73%.  
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